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Given the magnitude and severity of the 
threat of antimicrobial resistance, it is a 
sign of progress that Member States of 
the World Health Organization (WHO) 
are now developing national action 
plans in response to WHO’s Global ac-
tion plan on antimicrobial resistance.1 
To accelerate these efforts, in April 2016 
the Wellcome Trust held an interdisci-
plinary international summit, bringing 
together policy-makers and scientists 
from more than 30 countries to review 
and debate a set of 25 policy options.
The summit’s discussions reflected 
the multidimensional challenge posed 
by antimicrobial resistance. There are 
social, economic and environmental 
dimensions that encompass food pro-
duction systems as well as human and 
animal health.2 Public attitudes and 
behaviours have a major impact on 
antibiotic use in health care.3 In many 
countries, agricultural use of antibiotics 
exceeds medical use.4 The solutions to 
antimicrobial resistance must be simi-
larly broad in scope. The ‘One Health’ 
concept captures this scope, by recog-
nizing the interdependence of human 
health, agriculture and animal health 
and the environment.
There are multiple tools and a grow-
ing knowledge base to enable national 
decision-makers to address antimicro-
bial resistance. Although evidence gaps 
have been cited as barriers to action,5 
the summit concluded that knowledge 
gaps will always exist and that current 
evidence justifies immediate action. In 
particular, a range of policy interven-
tions need to be implemented in three 
key areas.
First, antibiotic use in agriculture 
must be phased out without compromis-
ing the food system’s capacity to meet 
increasing global demand. The use of 
antibiotics for growth promotion and 
disease prevention should be phased out 
in favour of improved animal husbandry 
practices. Given the potential economic 
impact of such measures, particularly 
in low- and middle-income countries, 
insurance schemes could be developed 
to mitigate the risk to farmers of income 
loss through lower productivity during 
this transition. Research into alternative 
treatments and husbandry practices 
is required to support reduced antibi-
otic use in agriculture. Food production 
systems should also do more to limit 
consumer exposure to drug-resistant 
microbes.
Second, we need to develop a much 
better understanding of drug resistance 
levels and antibiotic use at the local level, 
in both human and animal medicine. 
Surveillance and monitoring are needed 
to provide a clear picture of local situa-
tions and to assess the impact of inter-
ventions. More comprehensive data are 
required on both antibiotic usage and 
resistance. Quantitative data will enable 
policy-makers to track the impact of 
interventions and set targets to motivate 
changes in behaviour, and will increase 
accountability. 
Third, public health systems need to 
optimize antibiotic use and reduce the 
disease burden. Consistent with the sus-
tainable development goals, emphasis 
should be placed on improved sanitation 
and access to clean water, the promotion 
of good hand-hygiene practices and en-
hanced infection prevention and control 
in hospitals. By reducing infections and 
the need for antibiotics, these efforts 
would have an impact on antimicrobial 
resistance as well as delivering direct 
public health benefits. To promote these 
efforts, international development agen-
cies need to include the prevention of 
antimicrobial resistance as a core aspect 
of their work. In addition, health worker 
education and professional development 
should have a stronger emphasis on an-
tibiotic stewardship. Community-level 
education is necessary to ensure that 
all people understand what antibiotics 
can and cannot do and why minimizing 
use is in the interests of all. Over-the-
counter access to antibiotics needs to 
be minimized. At the same time, many 
countries need to improve access to ap-
propriate antibiotics. Measures are also 
needed to address the sale of antibiotics 
over the Internet. Financial incentives 
that link rewards to volumes of anti-
biotic sales also need to be eliminated.
Antimicrobial resistance affects 
every nation, but countries have varying 
needs and different capacities to address 
this challenge and face a multitude of 
competing health priorities. Neverthe-
less, every country can take actions that 
will directly benefit their own citizens 
while also helping to preserve our global 
antibiotic resources. Given that countries 
are at different stages in their development 
of response strategies, they should select 
policy interventions most appropriate to 
their circumstances, while building their 
capabilities over time. Sharing of informa-
tion captured during implementation of 
policy interventions will build an evidence 
base to support local implementation.
The global community has sufficient 
tools and knowledge to manage antimi-
crobial resistance effectively – and thereby 
achieve a safer and healthier world for all. 
We have a shared responsibility to sup-
port all countries as they take the actions 
needed to safeguard the health of their 
citizens and combat the global threat 
posed by antimicrobial resistance. ■
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